Readers of RNA Modification in Cancer and Their Anticancer Inhibitors

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Cancer treatment faces limitations with current technologies.
• Targeted therapy and epigenetics represent promising advancements.
• RNA readers are crucial in regulating RNA functions and cancer progression.

Purpose of the Study:

• To review various types of inhibitors targeting RNA readers.
• To elucidate the mechanisms of these inhibitors in suppressing cancer.
• To provide insights into developing novel anticancer drugs.

Main Methods:

• Comprehensive literature review of RNA reader inhibitors.
• Systematic analysis of non-coding RNA (ncRNA) inhibitors.
• Examination of small-molecule inhibitors and other potential agents.

Main Results:

• Identified diverse inhibitors targeting RNA readers.
• Elucidated mechanisms of cancer suppression via reader inhibition.
• Highlighted the potential of these inhibitors in targeted therapy.

Conclusions:

• Inhibitors targeting RNA readers are a key focus in epigenetic cancer research.
• These inhibitors show promise for advancing targeted cancer therapy.
• Further research into RNA reader inhibitors can lead to novel anticancer drug development.